Intranasal Technology is categorized under Wholesale Pharmaceutical Products in Lexington, KY and active since 2009.
Intranasal Technology was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Edwin Cochen at the company’s single location by writing to 1513 Bull Lea Road, Lexington, Kentucky KY 40511 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Intranasal Technology |
| Contact Person: | Edwin Cochen |
| Address: | 1513 Bull Lea Road, Lexington, Kentucky 40511 |
| Website Address: | intranasal.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Intranasal Technology was started in 2009 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Edwin Cochen for inquiries that concern Intranasal Technology by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Intranasal Technology can be found at the coordinates 38.087997,-84.494633 as well as the street address 1513 Bull Lea Road in Lexington, Kentucky 40511.
For its online presence, you may visit Intranasal Technology’s website at intranasal.com and engage with its social media outlets through on Twitter and on Facebook.